Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Dayang Red Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is a prominent producer of Vitamin B12 derivatives, most notably Mecobalamin, which is widely used for treating peripheral neuropathies and various forms of anemia. Beyond its core vitamin business, the firm manufactures a range of chemical drugs targeting cardiovascular health and metabolic disorders. Operating out of Ningbo, Zhejiang, the company maintains GMP-certified facilities and serves as a key supplier for both the domestic Chinese market and international pharmaceutical distributors. Its business model focuses on high-quality generic production and the supply of essential chemical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo Dayang Red Pharmaceutical.